Transcriptomic analysis of melanoma cells reveals an association of α-synuclein with regulation of the inflammatory response
The Parkinson's disease protein, alpha-synuclein (α-syn/SNCA), is highly expressed in neurons and melanomas. The goal of this study was to reveal the mechanism(s) of α-syn's involvement in melanoma pathogenesis. To decipher the genes and pathways affected by α-syn, we conducted an RNA sequencing analysis of human SK-MEL-28 cells and several SK-MEL-28 SNCA-KO clones. We identified 1098 significantly up-regulated genes and 660 significantly down-regulated genes. Several of the upregulated genes are related to the immune system, i.e., the inflammatory response and the matrisome. We validated five upregulated genes (IL-1β, SAA1, IGFBP5, CXCL8, and CXCL10) by RT-qPCR and detected IGFBP5 and IL-1β in spent media of control and SNCA-KO cells. The levels of each of these secreted proteins were significantly higher in the spent media of the SNCA-KO clones than control cells. These secreted proteins quite likely activate the immune response against SNCA-KO cells. We suggest that, conversely, high levels of α-syn expression in melanoma cells helps the cells evade the immune system by inhibiting the secretion of these immune activating factors.
Authors
- Siyuan Cheng (ORCID: https://orcid.org/0000-0002-4931-1403)
- Santhanasabapathy Rajasekaran (ORCID: https://orcid.org/0000-0002-3531-2448)
- Xiuping Yu (ORCID: https://orcid.org/0000-0003-2844-7026)
- Nithya Gajendran
- Sahar Shekoohi (ORCID: https://orcid.org/0009-0007-4545-4523)
- Stephan N. Witt (ORCID: https://orcid.org/0000-0002-6462-2840)
- Liudmila S. Chesnokova
Institutions
- Louisiana State University (US)
- Louisiana State University Health Sciences Center Shreveport (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1038/s41598-024-78777-6
- Citations
- 13
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.80
Funders
- Feist-Weiller Cancer Center